News

     
                  No items found     

2025

2024

2023

2022

2021

2020

December 17, 2020

SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

VIEW PRESS RELEASE

December 16, 2020

BioCardia, Inc. Announces $10.5 Million Registered Direct Offering Priced At-The-Market

VIEW PRESS RELEASE

December 14, 2020

BioCardia, Inc. Announces $8.5 Million Registered Direct Offering Priced At-The-Market

VIEW PRESS RELEASE

December 11, 2020

9 Meters Biopharma, Inc. Prices Public Offering of Common Stock

VIEW PRESS RELEASE

November 12, 2020

InMed Announces Pricing of US $8.0 Million Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"

VIEW PRESS RELEASE

2019

December 23, 2019

Monopar Therapeutics Inc. Announces Closing of Initial Public Offering of Common Stock

VIEW PRESS RELEASE

December 12, 2019

SCYNEXIS Announces Closing of $35 Million Public Offering of Common Stock and Warrants

VIEW PRESS RELEASE

October 22, 2019

Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

VIEW PRESS RELEASE

September 26, 2019

Vaxart Announces Pricing of $8 Million Underwritten Public Offering

VIEW PRESS RELEASE

August 6, 2019

BioCardia Announces Closing of $10.0 Million Public Offering

VIEW PRESS RELEASE